Abstract-Abnormal alterations in cerebrospinal fluid (CSF) flow are thought to play an important role in pathophysiology of various craniospinal disorders such as hydrocephalus and Chiari malformation. Three directional phase contrast MRI (4D Flow) has been proposed as one method for quantification of the CSF dynamics in healthy and disease states, but prior to further implementation of this technique, its accuracy in measuring CSF velocity magnitude and distribution must be evaluated. In this study, an MRcompatible experimental platform was developed based on an anatomically detailed 3D printed model of the cervical subarachnoid space and subject specific flow boundary conditions. Accuracy of 4D Flow measurements was assessed by comparison of CSF velocities obtained within the in vitro model with the numerically predicted velocities calculated from a spatially averaged computational fluid dynamics (CFD) model based on the same geometry and flow boundary conditions. Good agreement was observed between CFD and 4D Flow in terms of spatial distribution and peak magnitude of through-plane velocities with an average difference of 7.5 and 10.6% for peak systolic and diastolic velocities, respectively. Regression analysis showed lower accuracy of 4D Flow measurement at the timeframes corresponding to low CSF flow rate and poor correlation between CFD and 4D Flow in-plane velocities.
INTRODUCTION
Cerebrospinal fluid (CSF) serves many important roles in the central nervous system (CNS) including structural protection, 19 metabolic homeostasis, and immunological support. 17, 20 Abnormal CSF production, absorption, and/or dynamics are thought to play an important role in several CNS disorders such as Alzheimer's disease, 30, 35 hydrocephalus, 4 Chiari malformation, 5 and Syringomyelia. 9, 24 CSF has also been investigated as a transport route and medium for delivery of therapeutic molecules to neuronal and glial cells of CNS tissues. 29, 31 As such, a better understanding of CSF dynamics can improve the diagnosis and treatment of CNS disorders. Numerous studies have been carried out to assess CSF dynamics in the spinal subarachnoid space (SAS) using in vivo measurement techniques such as phase contrast magnetic resonance imaging (PCMRI) 22 and intraoperative ultrasound. More recently, the development of time-resolved three directional PCMRI sequences (4D Flow) has enabled the simultaneous measurement of velocities in through-plane and in-plane directions and allows for higher spatio-temporal resolution compared with conventional 2D PCMRI methods within a clinically feasible time-frame. 5, 32 Researchers have applied 4D Flow to investigate in vivo CSF velocity magnitudes and distribution in the spinal SAS. 5, 13 Due to its high spatio-temporal resolution and its ability to measure velocity components corresponding to secondary flows, 4D Flow has the potential for many clinical applications such as diagnostic measurements and prediction of intrathecal drug distribution. However, prior to further implementation of this technique, validation studies are needed to verify the accuracy of the obtained measurements.
The goal of the present study was to investigate the accuracy of 4D Flow measurements of CSF in terms of velocity magnitude and distribution. Our approach was to assess 4D Flow accuracy by comparing CSF velocities obtained from an in vitro subject-specific model of cervical SAS with numerically predicted velocities obtained from a spatially averaged computational fluid dynamics (CFD) model based on the same geometry and boundary conditions.
MATERIALS AND METHODS

Ethics Statement
The MRI data acquisition of the adult healthy volunteer was performed at the Department of Radiology at the University Hospital of Munster. The study was approved by the institutional review board of the University Hospital of Munster. Prior to completion of the MRI exams, written informed consent was obtained from the volunteer and the obtained data were anonymized before further processing.
Subject-Specific Model of Cervical SAS
MRI data acquisition was performed as previously described. 14 In brief, a three dimensional turbo spinecho sequence was used to obtain T2-weighted MRI images of the cervical spine with an isotropic spatial resolution of 0.8 mm. The three-dimensional geometry of cervical SAS, containing dura mater layer and spinal cord was reconstructed from the manual segmentation of MRI images using ITK Snap 37 (version 2.2, University of Pennsylvania, Philadelphia, Pennsylvania, USA) (Fig. 1a) . The geometry was segmented 5 cm caudal to the last cervical vertebra to reduce entrance length effects and the resulting surface model was smoothed to remove the pixilation artifacts.
In order to increase the anatomical fidelity of the model, idealized 3D spinal nerve rootlets were designed and added to the segmented geometry at each level along the spine using Autodesk Maya (version 2014, Autodesk Inc., Mill Valley, CA) based on the ex vivo measurements available in the literature 1 (Fig. 1b) . A more detailed modeling process of these fine structures and their corresponding dimensions is described in a previous work.
14 Note that in the present study, nerve rootlets were designed with a minimum thickness of 1 mm in order to meet the constraint imposed by the resolution of the 3D printer. The 3D printer limitation also made it impractical to include other fine anatomical features (i.e. denticulate ligaments) and thus these structures were not modeled in the current geometry. In order to make the model suitable for 3D printing, a hollow geometry was created by Boolean subtraction of the model from a rectangular cuboid (Fig. 1c) . The final composite models were inspected for topological inconsistencies using Geomagic Studio (3D System Corp., Valencia, CA) and exported as an STL files suitable for CFD grid generation and 3D printing.
Bench-Top Experimental Model
The composite geometry of the cervical SAS, including idealized nerve rootlets, was used to construct a phantom model (Fig. 1c) out of photo-reactive resin (Watershed XC 11122, DSM Somos Corp., Elgin, IL) using a stereolithography technique 18 (Viper si2 SLA system, 3D System Corp., Valencia, CA). The 3D printer layer thickness was 101.6 lm and the model was rigid and included additional extensions to provide necessary space for the flow system fittings.
The fluid used for the in vitro experiment was water, since its rheological properties is considered to be close to those of CSF. 3 A representative flow waveform with similar shape to that obtained in vivo was used for the experiment. The amplitude of the flow waveform was modulated so that the peak CSF velocities obtained from the in vitro experiment fall in the range observed by in vivo PC-MRI measurements. 5, 13 Each CSF flow pulsation created a stroke volume of~1.8 cm 3 with a maximum systolic and diastolic flow rate of 10.0 and 6.5 cm 3 /s in the craniocaudal and caudocranial directions, respectively.
The phantom model was placed within a flow system consisting of a computer-controlled pulsatile syringe pump, which simulated the desired CSF flow waveform. 24 The pulsatile pump consisted of a 3 ml precision glass syringe which was moved in a pulsatile manner by a tubular linear servo motor (TT Micro Model #TB1106, Copley Controls Corp., Canton, MA) according to a voltage signal generated by a laptop computer. Low viscosity spindle oil was used to lubricate the syringe shaft during the operation and a custom designed oil-water boundary cylinder was used to separate the syringe from the water entering the flow model. The pump was connected to the 3D printed model through a 7.6 m long, 6.4 mm ID rigid plastic tube. The use of this long tubing was necessary to keep all metallic components of the flow system away from the MRI scanner. The tubing that connected the pump and model was held in place to a solid surface at several locations by adhesive to minimize waveform degradation due to tubing motion.
4D Flow In Vitro Measurements
In vitro 4D Flow measurements were performed based on a previously detailed protocol. 5 In brief, a 1.5 T MRI (Achieva, Philips Healthcare, Best, Netherlands) equipped with a 16-channel head and neck coil was used and 4D Flow measurements were obtained from a retrospectively ECG triggered, gradient and RF spoiled, T1-weighted, segmented gradient echo sequence with acquired in plane and through-plane resolutions of 1.0 and 1.5 mm, respectively. Sequence parameters were as follows: Repetition time (TR) and Echo time (TE) was set to ''shortest'' resulting in a TR of 8.9 ms and a TE of 5.7 ms, flip angle: 5°. Images were collected in the sagittal orientation and flow velocities were encoded in anterior-posterior, in feethead and in right-left directions. The encoding velocity (V ENC ) was set to 15 cm/s for all direction and the cardiac cycle was temporally encoded in 16 phases, corresponding to an acquired temporal resolution of 52 ms. 4D Flow data was corrected for concomitant field induced phase offsets. 2 GTFlow software (version 2.2.6, Gyrotools Ltd., Zurich, Switzerland) was used for the post-processing of 4D Flow data including the correction for eddy current induced phase offsets 34 and aliasing artifacts. The in vitro model was submerged in a water bath during the scan and the surrounding water was considered as the static tissue for the eddy currents phase offsets corrections. Through-plane and in-plane velocities were obtained at eight different axial planes and exported as data files for further analysis and comparison with CFD results.
Numerical Flow Simulation
The composite geometry STL file was imported into ICEM CFD software (version 15.0, ANSYS Inc., Canonsburg, PA) and was discretized into a nonuniform unstructured rigid-walled computational grid with 12 million elements (Fig. 1d ). Grid refinement near the walls and nerve rootlets was used to accurately capture the larger gradients in these regions.
CFD simulation was carried out using ANSYS FLUENT (version 15.0, ANSYS Inc., Canonsburg, PA) and based on the methodology and setup described previously.
14 In brief, CSF was considered to be an incompressible Newtonian fluid and its rheological properties were assumed to be the same as those of water at the temperature during the in vitro experiments (26°C) and its flow was assumed to be laminar.4D Flow was chosen to obtain CFD boundary condition based on flow rates measured at eight axial planes, due to its significantly shorter scan time compared to traditional 2D PCMRI techniques. An inlet velocity profile based on the average of these measured flow rates was imposed on the cranial end of the geometry. Two hundred time-steps per cycle were computed for the simulation and results are presented based on the third flow cycle to minimize startup effects. Independence studies were performed for grid size, time-step size, and periodicity and described in the Supplementary Material.
While a detailed analysis of the CSF flow filed is possible by using CFD simulations due to their high spatial and temporal resolution, current clinically oriented 4D Flow measurement techniques are limited by their resolution, which is an order of magnitude lower than that of CFD. As such, a high resolution CFD simulation may produce some flow features that are undetectable by 4D Flow. This required averaging of the CFD simulation results for accurate comparison to the 4D Flow measurements.
The 4D Flow post-processing software used in the present study, GTFlow, linearly interpolated the raw MRI data onto a grid finer than the original voxel acquisition size. Interpolation of the 4D Flow output data was required to allow flow data analysis in any desired orientation within the flow field. Thus, the CFD results were spatially averaged to the original MR voxel resolution (1.5 and 1.0 mm through-plane and in-plane resolution, respectively) and then upsampled to the GTFlow software output resolution (0.49 mm isotropic). Post-processing of CFD results were carried out using an in-house code as shown in Fig. 2 .
Analysis and Comparison Method
For the qualitative and quantitative comparison of in vitro measurements and averaged CFD results, three-directional velocities were extracted at eight axial planes throughout the geometry. These axial planes were manually positioned in the space between foramen magnum (FM) and the midline of the seventh cervical vertebral bone (C7). An in-house MATLAB (MATLAB, MathWorks, Natick, MA) code was employed to quantify and compare CSF dynamics obtained from CFD and in vitro 4D Flow within individual axial planes. Quantified parameters included CSF flow rate, velocity distributions, and peak velocity magnitudes. More detailed comparison between simulation and in vitro experiment was made possible by performing a correlation analysis of local through-plane and in-plane CSF velocities between averaged CFD results and in vitro 4D Flow measurements. Pixel by pixel comparison of velocity component between CFD and 4D Flow at each axial plane was completed by matching the relative position of the corresponding structural images using a two-dimensional translational cross-correlation technique in MATLAB (xcorr2). For each pixel, the value of the local CFD velocity was plotted against the corresponding value obtained from 4D Flow measurement and linear regression analysis was performed for all axial planes and timeframes.
RESULTS
4D Flow Measured Flow Rate Variability
CSF flow rate was quantified from in vitro 4D Flow measurements at eight different axial planes during the cardiac cycle with a typical systolic and diastolic peak flow rate of 12.0 and 7.0 ml/s, respectively. The waveform shape was maintained by each axial plane as expected with an average standard deviation of 0.36 ml/s over all timeframes (Fig. 3 ). While the agreement among different axial planes was relatively good, a maximum difference of 18% was observed between waveforms measured at FM and C5 axial planes at peak systole. A similar trend was observed for the standard deviation of flow rate with the maximum of 0.79 ml/s measured at peak systole. Figure 4 compares the surface plots of the throughplane velocities obtained from CFD and in vitro 4D Flow at peak systole and peak diastole. Note that Fig. 4 color scales are varied for each axial plane to maximize the details shown. Good agreement was observed in terms of spatial distribution and peak magnitude of through-plane velocities. Both the in vitro and CFD results showed anterior dominance of the CSF flow in the axial planes near the cranial end of the geometry (C1 and C2) and also regions of elevated flow between nerve rootlets, albeit these flow features were more pronounced in the simulation results.
Qualitative Comparison of Velocity Patterns
Some differences were observed between the profile shapes obtained from CFD simulation and in vitro measurements which were more pronounced at the axial planes near the cranial end of the geometry and also near the edges of the axial planes and the nerve rootlets (red arrows in Fig. 4 ). Despite the overall qualitative agreement in velocity distributions, the exact in-plane location of distinct peak velocity values (e.g. jets) varied between the CFD and in vitro results. The maximum spatial distance of these peak velocity values in the CFD and in vitro results ranged up to 15 mm in distance within each plane. Also, spatial and temporal velocity variations with a magnitude of~1-2 cm/s were observed at some locations in 4D Flow velocity profiles that were not observed in CFD results.
The discrepancy of in-plane velocities was much greater than that of the through-plane velocities. tative axial plane (C1). A significant difference was observed in in-plane velocity magnitudes and directions, as 4D Flow in-plane velocities pointed in different directions and appeared to lack the coherence seen in CFD results. Also, secondary flow features, such as vortices, occurred in one data set but not in the other.
Quantitative Comparison of Velocities
A detailed quantitative comparison between in vitro and CFD results was performed at the axial planes over the cardiac cycle. Figure 6 illustrates the comparison of peak CSF velocities obtained from CFD simulation and in vitro measurements for all axial planes at peak systole and diastole. A good agreement was observed between CFD and 4D Flow peak CSF velocities at different axial planes. Average difference over all planes for peak systolic and diastolic CSF velocities between CFD and 4D Flow was 0.85 ± 0.79 and 0.73 ± 0.39 cm/s, respectively with a maximum difference of 36% that occurred at the FM at peak diastole. Larger discrepancies in CSF velocities were observed at timeframes when flow rate was nearly zero (up to 150%, not shown in Fig. 6 ).
Differences between through-plane velocities obtained from in vitro 4D Flow and CFD were further quantified using Bland-Altman plots as shown in Fig. 7 . The results shown in Fig. 7 correspond to all cardiac timeframes and are plotted for the axial planes with highest and lowest correlation coefficient between CFD and 4D Flow through-plane velocities (C3 and FM, respectively). Close correlation was observed from the linear regression analysis in both planes (r = 0.81 and 0.93 for FM and C3, respectively), although the correlation at the FM proved to be less favorable, evident from its lower r and slope values. The second set of Bland-Altman plots showed that the value of discrepancy between CFD and in vitro results can be higher for greater CSF velocities and that the 95% confidence intervals were limited by 1.2-1.8 cm/s velocities, similar to the values seen for the random fluctuations of 4D Flow velocities mentioned above.
The results of the linear regression analysis averaged over all axial planes are summarized in Fig. 8a , which Fig. 1 ) and at the timeframes corresponding to peak systole (left) and peak diastole (right).
shows the calculated slopes and correlation coefficient as a function of timeframes. Good correlation of 4D Flow measurements and CFD results (r > 0.75) was observed at most of the timeframes. Higher values of mean correlation coefficient and mean slope were measured near peak systole (timeframe 8), while a large standard deviation in slope and weaker correlation between CFD and 4D Flow velocities were observed at the timeframes corresponding to near zero CSF flow rate (CSF flow reversal at timeframes 6 and 12 in Fig. 8a ). Figure 8b depicts the variation of mean slopes and correlation coefficients averaged over all timeframes as a function of axial location. Overall, good correlation was observed between 4D Flow and CFD. However, the mean slopes and correlation coefficients were lower in the axial planes near the cranial end of the geometry (Fig. 8b) . This is reflected by the increased mismatch of CFD and in vitro results at the cranial region. Also, the mean slope values were consistently below unity in both Figs. 8a and 8b, indicating a tendency of the CFD simulation to overestimate the CSF velocities measured by 4D Flow.
As expected from the qualitative comparison of inplane velocities, poor correlation coefficients were calculated from the linear regression analysis of inplane velocities obtained from CFD and 4D Flow. The maximum values of mean correlation coefficients averaged over all axial planes and all timeframes were 0.52 ± 0.19 and 0.50 ± 0.10 that was measured at the 9th timeframe and C8 axial plane, respectively. Figure 9 depicts the variability in CFD peak through-plane velocity contours for a representative axial plane over a distance of 1.0 mm, which is equivalent to the through-plane slice thickness of 4D Flow measurements. Despite having a similar range of magnitude, velocity distribution patterns showed some alteration, especially near the regions with greater geometrical variation (near nerve rootlets). These alterations highlight the need for spatial averaging of the CFD results before comparison with 4D Flow and also the added flow detail that CFD can provide. As shown in Fig. 9 , averaging of CFD velocities decreased peak through-plane velocity magnitude up to 25%. Also, some flow features such as anterolateral dominance of the flow and concentrated flow regions between nerve rootlets were weakened or completely diminished as a result of averaging.
Impact of Spatial Averaging on the Numerical Results
DISCUSSION
Quantitative assessment of CSF dynamics is thought to be important because of its potential application to help characterize CNS disorders such as Chiari malformation, 5,9 predict CSF pressure gradients 12 and predict intrathecal drug distribution. 16 In vivo 4D Flow assessment of CSF hydrodynamics is desirable because all velocity components can be directly obtained in a 3D region of interest; whereas, MRI-based CFD techniques require a number of assumptions and simplifications. However, before reaching a broad clinical use, the accuracy of 4D Flow measurement of CSF velocities must be verified. To assess accuracy, our approach was to construct and test an anatomically realistic in vitro model of the cervical SAS and verify the results against a numerical simulation. Construction and testing of the anatomically realistic in vitro model, as a means for comparison of the CFD and 4D Flow measurements, allowed control of the geometry and flow boundary conditions that is not possible with in vivo measurements. Herein, our discussion focuses on qualitative and quantitative comparison of thru-plane and secondary velocity results and highlights the possible sources of error due to the 4D Flow and CFD post-processing methods.
Agreement of Thru-Plane CSF Velocities
Our findings showed a good qualitative and quantitative agreement between the numerical simulation and in vitro 4D Flow measurements in terms of through-plane velocities (Fig. 4) . Albeit, the magnitude of thru-plane peak velocities was generally greater in the CFD results compared to 4D Flow (Fig. 6) . The comparison of through-plane velocity profile shapes revealed similar flow characteristics, as the overall velocity distribution and also more distinctive flow features, such as anterior dominance of flow and anterolateral jets, were detected by both techniques (Fig. 4) . Quantitative comparison of CFD and in vitro data yielded a close correlation of through-plane velocities at most axial planes and timeframes (Fig. 8) . The correlation was particularly strong at the timeframes corresponding to peak systolic and diastolic CSF flow and at axial locations with greater CSF velocities.
In previous assessments of CSF velocities using in vivo 4D Flow measurements, large discrepancies were reported between in vivo 4D Flow and MRIbased CFD models in terms of velocity magnitude and distribution at peak systole. 36 For example, Yiallourou et al. 36 and Pahlavian et al. 13 reported a large difference between peak CSF velocities measured by 4D Flow and calculated from CFD in healthy volunteers (up to 300%) and patients diagnosed with Chiari malformation (up to 600%). Also, a substantial difference was reported in velocity distributions measured by 4D Flow and predicted by CFD, characterized by more pronounced anterior and anterolateral dominance of the flow in in vivo measurements. The reported differences between CFD and in vivo measurements were located at high CSF velocity regions. Thus, the present study results support that the previous in vivo 4D Flow measurements were likely correct and that the differences in CFD results were due to modeling simplification and/or assumptions such as the SAS geometry and absence of compliance and/or porosity in the model. These differences were not likely to be due to operator segmentation error. 25 Despite the general good agreement between CFD and in vitro results, some discrepancies were observed in the through-plane velocities obtained from these methods. In terms of overall velocity distribution, a greater mismatch between CFD and in vitro results was observed on axial planes closer to the cranial end of the geometry (Fig. 4) . Also, a weaker correlation between CFD and in vitro through-plane velocities was observed at planes near this region (Fig. 8b) . One possible reason for this could be the lower velocity to noise ratio (VNR) of 4D Flow measurements at these planes due to their larger cross-sectional area and lower velocities. A high value of the V ENC parameter produces low VNR in the low velocity flow regions and hinders the precise capturing of the detailed flow structures in these regions. 11 In the present study a V ENC value of 15 cm/s was used, yet the peak velocities at axial planes near the cranium were much lower at 6-8 cm/s. Also, local velocities at these planes were as low as 1 cm/s in a relatively large portion of the area (see posterior side of FM and C1 during diastole in Fig. 4 ). This limitation in 4D Flow measurements can also explain the weak correlation between CFD and in vitro through-plane velocities at the timeframes close to CSF flow reversal (near zero flow rate). The precision of 4D Flow can be enhanced for measuring lower velocities by using a multiple V ENC sequences 11 and/or using a time-dependent V ENC . Furthermore, detailed comparison of through-plane velocity profile shapes revealed regions with local discrepancies, which were mainly located near the nerve rootlets (red arrows in Fig. 4 ). The other difference observed in velocity patterns was the spatiotemporal velocity fluctuations in 4D Flow results which were not present in CFD velocities. The exact cause of these fluctuations is unclear, but 4D Flow measurement artifacts and noise could have contributed to their formation. 
Poor Similarity of Secondary Flow Components
Our results show that measured in-plane 4D Flow velocities are not accurate in the current geometry. The in-plane velocities obtained from 4D Flow showed a high degree of noise and incoherence in comparison to CFD (Fig. 5) . These discrepancies are mainly the result of the 4D Flow error due to the low in-plane velocity magnitudes and were observed in previous studies of blood flow measurements. 21 As such, improvement of 4D Flow sequences through implementation of lower V ENC for in-plane velocities or multiple V ENC acquisitions should be performed prior to further consideration of this technique for quantification of secondary flow components. Secondary components of CSF flow can have an important impact on its mixing characteristics and could be used to enhance the prediction of intrathecal drug distribution. 14, 16, 27, 29 Lack of Consistency in 4D Flow Measured CSF Flow Waveforms
Despite using a rigid phantom model, axial variations were observed in the 4D Flow-measured volumetric CSF flow rate throughout the geometry (Fig. 3) . A maximum difference of 18% was measured between FM and C5 axial planes at the timeframe corresponding to peak CSF flow rate. Similar discrepancies in PCMRI-measured flows were reported in previous in vitro assessment of blood velocities, 21, 26 albeit with lower error of 5-6%.
The observed variation could be caused by 4D Flow measurement error and post-processing. In the present study, 4D Flow data underwent a linear eddy current correction. Although 1 st order eddy-current corrections have been performed on the 4D Flow measurements, remaining errors are likely due to phase offsets not correctible by the eddy current correction algorithm. These include higher order eddy currents but also eddy-current variations throughout the segmented acquisition due to steady-state loss and/or temperature variations of the gradient system. 10 Another source of error that remains in the 4D Flow data that could explain the higher velocity discrepancies at the field of view edges are gradient field distortions and their effect on the V ENC. 23 One approach for reducing the aforementioned errors is the incorporation of recently developed divergence-free de-noising processing techniques, 7, 28 which enforce physical constraint of fluid incompressibility to the measured flow field. These noise reduction features were not available in the postprocessing software used in the current study.
The axial variation of CSF flow rate along cervical SAS was previously reported in in vivo PCMRI studies and its presence was postulated to be indicative of SAS compliance. 13, 36 The presence of CSF flow variations along the rigid in vitro model, with exactly the same flow waveform present throughout the model, revealed that SAS compliance may not be the sole reason behind this phenomenon and it could be, in part, due to an artifact of 4D Flow measurements.
Importance of Post-Processing and Limitations of CFD and Experimental Methods
An important methodological aspect of the present study was the post-processing and spatial averaging of CFD data prior to their comparison with 4D Flow measurements. Our results demonstrate that velocity distribution details are diminished as a result of the spatial averaging that is necessary to obtain 4D Flow data (Fig. 9) . In particular, spatial averaging resulted in up to a 25% reduction in peak CSF velocities. This result indicates that the peak in vivo CSF velocities detected by 4D Flow in previous studies 5, 6, 36 could be substantially greater than realized. Future improvement of 4D Flow sequences are needed for enhancing its spatial and temporal resolution, particularly for situations where it is critical to quantify highly resolved flow patterns.
The CFD simulation conducted in this study had a number of limitations. For the flow boundary condition, we applied a CSF flow rate detected by 4D Flow (Fig. 3) . This methodology was applied in a number of previous in vitro MRI studies in the literature. 8, 21 The CFD simulation was performed using a laminar flow assumption. The maximum Reynolds number, based on internal flow, was calculated to be 960. Thus, it is possible that some local transitional flow features were present in the in vitro model. 15 Additional experimental measurements of parameters such as flow rate and pressure gradient would further describe the flow field inside the in vitro model. However, these measurements are difficult to perform accurately due to the small amplitudes of both flow and pressure gradient waveforms. Also, 4D Flow measurements are phase-averaged and thus do not allow quantification of high-frequency velocity fluctuations that may be present in the CSF flow. Emerging works pertaining to real-time phase-contrast 
MRI
33 might prove to be useful in detection of these velocity fluctuations.
Although the 3D printing layer thickness of 101.6 lm was smaller than the segmentation resolution (800 lm), it still resulted in non-smooth surfaces in the constructed model, which were not present in the geometry used in the CFD model. This surface roughness is expected to have a minor impact on the measured velocities, due to its small size and the relatively low Reynolds number of CSF flow. Controlled treatment of the constructed geometry using abrasive flow deburring might be useful to minimize the impact of the surface roughness created during the 3D printing process. However, such techniques have the risk of altering the geometry beyond roughness correction.
CONCLUSION
The accuracy of 4D Flow detection of CSF dynamics in the cervical spine was assessed by usage of an in vitro model and comparison to a numerical simulation. 4D Flow was found to accurately measure through-plane CSF velocities and distribution throughout the cervical SAS at timeframes near peak systolic and diastolic CSF flow rates. In-plane assessment of CSF velocities and CSF velocities at low flow rates (e.g. near flow reversal) were not found to be accurate. These results support the use of 4D Flow to assess CSF velocities as an indicator of CNS disease states.
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